HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact Its Attorneys Now, Securities Fraud Class Action Pending, Deadline Approaching
April 26, 2021 14:42 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, April 26, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15,...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact Its Attorneys Now, Securities Fraud Class Action Filed
April 20, 2021 15:45 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, April 20, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. Class Period: June 15,...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys
April 06, 2021 15:39 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, April 06, 2021 (GLOBE NEWSWIRE) -- Hagens Berman invites Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. The firm is...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys
March 24, 2021 14:34 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 24, 2021 (GLOBE NEWSWIRE) -- Hagens Berman invites Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. The firm is...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Acadia Pharmaceuticals (ACAD) For Possible Securities Law Violations, Encourages Investors with Losses to Contact Its Attorneys
March 10, 2021 16:02 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 10, 2021 (GLOBE NEWSWIRE) -- Hagens Berman invites Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now. The firm is...
Hagens Berman Reminds Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) of the September 17, 2018 Securities Class Action Lead Plaintiff Deadline
September 04, 2018 17:05 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) of the September 17, 2018 Lead Plaintiff deadline in...
Hagens Berman Reminds Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) of the September 17, 2018 Securities Class Action Lead Plaintiff Deadline
August 03, 2018 16:32 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) of the September 17, 2018 Lead Plaintiff deadline in...
Hagens Berman Alerts Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) to the September 17, 2018 Securities Class Action Lead Plaintiff Deadline
July 20, 2018 16:59 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 20, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to the September 17, 2018 Lead Plaintiff deadline in...